Christopher Haskell BS, PhD

Christopher Haskell has over ten years of experience in drug development, including programs in small molecule compounds and biologics, in both early research as well as clinical development programs. As a Head of US Science Hub at Bayer, he focused on developing innovative business and collaboration models that drive the project to clear decision points based on solid science.